Teva Pharma Wins Race to Acquire Ratiopharm (TEVA)
Thursday, March 18, 2010 - 07:25
Written on Thu, 03/18/2010 - 7:25am
By Chip Brian

3/18/2010-Israeli drug maker Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) has won the race to acquire generic drug maker Ratiopharm Group International, several people familiar with the matter told Dow Jones Newswires Thursday.
"Actavis hasn't put in a binding bid and thus is out. Everything points to Teva as buyer of Ratiopharm," one of the people said.
Another person said "Teva was willing to make the highest bid" and therefore will have won the race.

Keywords: pharmaceuticals Ratiopharm acquisition

Ticker(s): TEVA BID

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.